Honors & Awards

  • Short-term stay fellowship, University of Granada (2018)
  • Short-term stay fellowship, Ministry of Education of Spain (2017)
  • Predoctoral fellowship FPU, Ministry of Education of Spain (2015-2019)

Professional Education

  • Postdoctoral fellow, University of Granada (2019)
  • Doctor of Philosophy, Universidad De Granada (2019)
  • Master of Science, Universidad De Granada (2014)
  • Bachelor of Science, Universidad De Granada (2013)

Stanford Advisors


All Publications

  • PCR-free and chemistry-based technology for miR-21 rapid detection directly from tumour cells TALANTA Delgado-Gonzalez, A., Robles-Remacho, A., Marin-Romero, A., Detassis, S., Lopez-Longarela, B., Javier Lopez-Delgado, F., de Miguel-Perez, D., Guardia-Monteagudo, J. J., Antonio Fara, M., Tabraue-Chavez, M., Pernagallo, S., Sanchez-Martin, R. M., Diaz-Mochon, J. J. 2019; 200: 51–56


    miRNAs are well known for being implicated in a myriad of biological situations, including those related to serious diseases. Amongst miRNAs, miRNA-21 has the spotlight as it is reported to be up-regulated in multiple severe pathological conditions, being its quantification a key point in medicine. To date, most of the techniques for miRNA quantification have shown to be less effective than expected; thus, we herein present a novel, rapid, cost-effective, robust and PCR-free approach, based on dynamic chemistry, for the identification and quantification of miRNA directly from tumour cells using both FACS and a fluorescent microplate. This dynamic chemistry novel application involves bead based reagents and allows quantifying the number of miR-21 molecules presented in MDA-MB-468 and H1975 tumour cells.

    View details for DOI 10.1016/j.talanta.2019.03.039

    View details for Web of Science ID 000468715300007

    View details for PubMedID 31036216

  • Drug "Clicking" on Cell-Penetrating Fluorescent Nanoparticles for In Cellulo Chemical Proteomics BIOCONJUGATE CHEMISTRY Valero, T., Delgado-Gonzalez, A., Diego Unciti-Broceta, J., Cano-Cortes, V., Perez-Lopez, A. M., Unciti-Broceta, A., Sanchez Martin, R. M. 2018; 29 (9): 3154–60


    Chemical proteomics approaches are widely used to identify molecular targets of existing or novel drugs. This manuscript describes the development of a straightforward approach to conjugate azide-labeled drugs via click chemistry to alkyne-tagged cell-penetrating fluorescent nanoparticles as a novel tool to study target engagement and/or identification inside living cells. A modification of the Baeyer test for alkynes allows monitoring the Cu(I)-catalyzed azide-alkyne cycloaddition (CuAAC) reaction, guaranteeing the presence of the drug on the solid support. As a proof of concept, the conjugation of the promiscuous kinase inhibitor dasatinib to Cy5-labeled nanoparticles is presented. Dasatinib-decorated fluorescent nanoparticles efficiently inhibited its protein target SRC in vitro, entered cancer cells, and colocalized with SRC in cellulo.

    View details for DOI 10.1021/acs.bioconjchem.8b00481

    View details for Web of Science ID 000445439500029

    View details for PubMedID 30122043

  • Metallofluorescent Nanoparticles for Multimodal Applications ACS OMEGA Delgado-Gonzalez, A., Garcia-Fernandez, E., Valero, T., Cano-Cortes, M., Ruedas-Rama, M. J., Unciti-Broceta, A., Sanchez-Martin, R. M., Diaz-Mochon, J. J., Orte, A. 2018; 3 (1): 144–53


    Herein, we describe the synthesis and application of cross-linked polystyrene-based dual-function nano- and microparticles containing both fluorescent tags and metals. Despite containing a single dye, these particles exhibit a characteristic dual-band fluorescence emission. Moreover, these particles can be combined with different metal ions to obtain hybrid metallofluorescent particles. We demonstrate that these particles are easily nanofected into living cells, allowing them to be used for effective fingerprinting in multimodal fluorescence-based and mass spectrometry-based flow cytometry experiments. Likewise, the in situ reductions of the metal ions enable other potential uses of the particles as heterogeneous catalysts.

    View details for DOI 10.1021/acsomega.7b01984

    View details for Web of Science ID 000427933200016

    View details for PubMedID 30023770

    View details for PubMedCentralID PMC6044963

Latest information on COVID-19